Immune CD8+ T cells prevent reactivation of Toxoplasma gondii infection in the immunocompromised host

被引:38
作者
Khan, IA
Green, WR
Kasper, LH
Green, KA
Schwartzman, JD
机构
[1] Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA
[2] Dartmouth Med Sch, Dept Microbiol, Lebanon, NH 03756 USA
[3] Dartmouth Med Sch, Dept Pathol, Lebanon, NH 03756 USA
关键词
D O I
10.1128/IAI.67.11.5869-5876.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toxoplasma gondii remains a serious cause of morbidity and mortality in individuals that are immunosuppressed, patients with AIDS in particular. The cellular immune response, especially by gamma interferon (IFN-gamma)-producing CD8(+) T cells, is an essential component of protective immunity against the parasite. In the present study the role of CD8(+) T cells during the reactivation of Toxoplasma infection in an immunocompromised murine model was evaluated, Chronically infected mice were challenged with LP-BM5 virus, and the kinetics of CD8(+) T-cell function was studied. At 10 weeks after viral infection, mice showed obvious signs of systemic illness and began to die, At this stage, CD8(+) T cells were unresponsive to antigenic stimulation and unable to kill Toxoplasma-infected targets. IFN-gamma production by the CD8(+) T cells from dual-infected animals reached background levels, and a dramatic fall in the frequency of precursor cytotoxic T lymphocytes was observed. Histopathological analysis of the tissues demonstrated signs of disseminated toxoplasmosis as a result of reactivation of infection. However, treatment of the dual-infected animals with immune CD8(+) T cells at 5 weeks post-LP-BM5 challenge prevented the reactivation of toxoplasmosis, and mice continued to live. Our study for the first time demonstrates a therapeutic role for CD8(+) T cells against an opportunistic infection in an immunocompromised state.
引用
收藏
页码:5869 / 5876
页数:8
相关论文
共 40 条
[11]   OPPORTUNISTIC INFECTIONS AND RETROVIRUS-INDUCED IMMUNODEFICIENCY - STUDIES OF ACUTE AND CHRONIC INFECTIONS WITH TOXOPLASMA-GONDII IN MICE INFECTED WITH LP-BM5 MURINE LEUKEMIA VIRUSES [J].
GAZZINELLI, RT ;
HARTLEY, JW ;
FREDRICKSON, TN ;
CHATTOPADHYAY, SK ;
SHER, A ;
MORSE, HC .
INFECTION AND IMMUNITY, 1992, 60 (10) :4394-4401
[12]   TOXOPLASMA-GONDII SEROLOGY IN HIV-INFECTED PATIENTS - THE DEVELOPMENT OF CENTRAL-NERVOUS-SYSTEM TOXOPLASMOSIS IN AIDS [J].
GRANT, IH ;
GOLD, JWM ;
ROSENBLUM, M ;
NIEDZWIECKI, D ;
ARMSTRONG, D .
AIDS, 1990, 4 (06) :519-521
[13]  
HAKIM FT, 1991, J IMMUNOL, V147, P2310
[14]  
HO M, 1993, BLOOD, V81, P2093
[15]   MICE WITH AN ACQUIRED IMMUNODEFICIENCY (MAIDS) DEVELOP A PERSISTENT INFECTION AFTER INJECTION WITH LISTERIA-MONOCYTOGENES [J].
HUGIN, AW ;
CERNY, A ;
MORSE, HC .
CELLULAR IMMUNOLOGY, 1994, 155 (01) :246-252
[16]  
KHAN IA, 1991, J IMMUNOL, V147, P3501
[17]  
Khan IA, 1996, J IMMUNOL, V157, P2103
[18]   INDUCTION OF ANTIGEN-SPECIFIC HUMAN CYTOTOXIC T-CELLS BY TOXOPLASMA-GONDII [J].
KHAN, IA ;
SMITH, KA ;
KASPER, LH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1879-1886
[19]  
KHAN IA, 1994, J IMMUNOL, V152, P1856
[20]  
KLINKEN SP, 1988, J IMMUNOL, V140, P1123